BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1977939)

  • 1. Evaluation of a new vasodilating beta-blocking agent, carvedilol, in exertional angina using holter monitoring.
    Kishida H; Saito T; Fukuma N; Hata N; Suzuki T; Ohtsu F
    Jpn Heart J; 1990 Jul; 31(4):449-60. PubMed ID: 1977939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antianginal efficacy of carvedilol, a beta-blocking drug with vasodilating activity.
    Rodrigues EA; Lahiri A; Hughes LO; Kohli RS; Whittington JR; Raftery EB
    Am J Cardiol; 1986 Nov; 58(10):916-21. PubMed ID: 2877564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of carvedilol (BM 14,190), a new beta-blocking drug with vasodilating properties, in exercise-induced ischemia.
    Kaski JC; Rodriguez-Plaza L; Brown J; Maseri A
    Am J Cardiol; 1985 Jul; 56(1):35-40. PubMed ID: 2861738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol versus verapamil in chronic stable angina: a multicentre trial.
    Hauf-Zachariou U; Blackwood RA; Gunawardena KA; O'Donnell JG; Garnham S; Pfarr E
    Eur J Clin Pharmacol; 1997; 52(2):95-100. PubMed ID: 9174677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of safety and efficacy of carvedilol and metoprolol in stable angina pectoris.
    van der Does R; Hauf-Zachariou U; Pfarr E; Holtbrügge W; König S; Griffiths M; Lahiri A
    Am J Cardiol; 1999 Mar; 83(5):643-9. PubMed ID: 10080412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of carvedilol in exercise-induced myocardial ischemia.
    Kaski JC; Rodriguez-Plaza L; Brown J; Maseri A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S137-40. PubMed ID: 2454360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of carvedilol and atenolol for angina pectoris.
    Freedman SB; Jamal SM; Harris PJ; Kelly DT
    Am J Cardiol; 1987 Sep; 60(7):499-502. PubMed ID: 2888302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of carvedilol in unstable angina pectoris.
    Brunner M; Faber TS; Greve B; Keck A; Schnabel P; Jeron A; Meinertz T; Just H; Zehender M
    Am J Cardiol; 2000 May; 85(10):1173-8. PubMed ID: 10801996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antianginal efficacy of carvedilol, a new beta-blocker with vasodilating action.
    Jamal SM; Freedman SB; Thomson A; Carter G; Harris PJ; Kelly DT
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S141-6. PubMed ID: 2454361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a new vasodilating beta-blocking drug, carvedilol, on left ventricular function in stable angina pectoris.
    Lahiri A; Rodrigues EA; Al-Khawaja I; Raftery EB
    Am J Cardiol; 1987 Apr; 59(8):769-74. PubMed ID: 2881480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of carvedilol and atenolol efficacy in patients with stable effort angina].
    Martsevich SIu; Koniakhina IP; Alimova EV; Kutishenko NP; Lerman OV
    Ter Arkh; 2001; 73(1):38-41. PubMed ID: 11234138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of carvedilol with a combination of propranolol and isosorbide dinitrate in the chronic treatment of stable angina.
    Nahrendorf W; Rading A; Steinig G; van der Does R; Schlote A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S114-6. PubMed ID: 1378136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new antianginal agent, nipradilol, in effort angina using holter monitoring.
    Kishida H; Saito T; Nejima J; Hata N; Kusama Y; Suzuki T; Otsu F; Kaneko H; Inokuchi N
    Jpn Heart J; 1988 May; 29(3):309-17. PubMed ID: 2902238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of three different doses of carvedilol for exertional angina. Carvedilol-Angina Study Group.
    Weiss R; Ferry D; Pickering E; Smith LK; Dennish G; Krug-Gourley S; Lukas MA
    Am J Cardiol; 1998 Oct; 82(8):927-31. PubMed ID: 9794346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of carvedilol in comparison with nifedipine sustained-release in chronic stable angina.
    van der Does R; Eberhardt R; Derr I; Ehmer B
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S122-7. PubMed ID: 1378139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of carvedilol in congestive heart failure secondary to coronary artery disease.
    Das Gupta P; Broadhurst P; Raftery EB; Lahiri A
    Am J Cardiol; 1990 Nov; 66(15):1118-23. PubMed ID: 1977300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilating beta-blockers in heart failure.
    Raftery EB
    Eur Heart J; 1995 Jul; 16 Suppl F():32-7. PubMed ID: 8521882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of carvedilol in patients with impaired left ventricular function due to ischaemic heart disease.
    Lahiri A; Rodrigues EA; DasGupta P; Jain D; van der Does R; Raftery EB
    Z Kardiol; 1989; 78 Suppl 3():21-7. PubMed ID: 2573213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple action compounds in angina pectoris.
    Kelly DT; Freedman SB
    Z Kardiol; 1989; 78 Suppl 3():16-20. PubMed ID: 2573212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic stable angina with carvedilol in comparison with nifedipine s.r.
    van der Does R; Eberhardt R; Derr I; Ehmer B; Rudorf J; Uberbacher HJ
    Eur Heart J; 1991 Jan; 12(1):60-4. PubMed ID: 2009895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.